Sr. Director, Medical Affairs, Inherited Neurometabolic Disorders (IMD)

ITF Therapeutics

Concord (MA)

On-site

USD 290,000 - 320,000

Full time

47 hours ago
Be an early applicant

A complete application in a minute

Tailored resume and cover letter, ready to send.

Get past ATS filters

Benefits offered by this job

Base salary with comprehensive package

Job summary

ITF Therapeutics in the United States seeks a Sr. Director of Medical Affairs for Inherited Neurometabolic Disorders. You will lead the U.S.

medical strategy, plan launches, and ensure alignment with global medical strategy and evidence generation. The role demands strategic leadership, deep rare disease expertise, and cross-functional collaboration to deliver patient-focused healthcare outcomes. You will oversee medical education, external engagement, and payer strategies, partnering with

Qualifications

  • MD, PharmD, or PhD in a relevant medical or scientific field.
  • 12+ years in Medical Affairs, Clinical Development, or related areas.
  • Proven success leading U.S. Medical Affairs and rare-disease launches.
  • Experience partnering with Global Medical Affairs in a matrixed org.
  • Ability to influence global strategy with U.S. insights.

Responsibilities

  • Lead the U.S. Medical Affairs strategy across pre-launch, launch, and lifecycle.
  • Serve as senior U.S. medical leader for neurometabolic diseases.
  • Coordinate with Commercial, Market Access, Regulatory and Global teams.
  • Oversee medical communications, education, and payer engagement.
  • Drive evidence generation planning, publication strategy, and data dissemination.
  • Build and develop a high-performing U.S. Medical Affairs team.
  • Represent ITF Therapeutics at scientific and advocacy forums.

Skills

Medical leadership
KOL engagement
Global collaboration
Evidence generation
Strategic influence
Team leadership

Education

MD/PhD/PharmD

Job description

Reports to: VP, US Medical Affairs & Patient Advocacy

About This Role:

The Sr. Director, Medical Affairs, Inherited Neurometabolic Disorders (IMD) is responsible for leading the U.S. Medical Affairs strategy for ITF Therapeutics' rare neurometabolic disease portfolio. Reporting to the Vice President of Medical Affairs & Patient Advocacy, this role serves as the senior U.S. medical leader for the neurometabolic therapeutics portfolio, ensuring effective translation of global medical strategy into impactful U.S. plans and successful launch execution.

As a member of the US Medical Affairs leadership team, the Senior Director provides strategic and scientific leadership across product development and commercialization, with responsibility for U.S. medical strategy, launch readiness, scientific engagement, field medical effectiveness, medical communications, education, payer engagement, and cross-functional execution.

Working closely with the Global Medical Director, this individual serves as the primary U.S. medical voice for the neurometabolic portfolio, ensuring global evidence generation, scientific communications, and medical activities address the needs of U.S. patients, healthcare professionals, payers, and other stakeholders.

The successful candidate will bring deep rare disease expertise, strong scientific and strategic leadership, and the ability to influence within a matrixed global organization. This leader will foster scientific excellence, collaboration, patient centricity, and innovation while helping establish ITF Therapeutics as a trusted partner within the neurometabolic community.

What You'll Do:
U.S. Medical Strategy & Leadership
  • Lead development and execution of integrated U.S. Medical Affairs strategies and tactical plans across pre-launch, launch, and lifecycle stages for the neurometabolic therapeutics portfolio.
  • Serve as the senior U.S. medical leader for target neurometabolic diseases, ensuring medical strategies support appropriate patient identification, disease knowledge, product knowledge, and improved patient outcomes.
Medical Launch Excellence
  • Lead all U.S. medical launch planning and execution activities related to the neurometabolic therapeutics portfolio.
  • Establish launch readiness plans spanning field medical, scientific communications, medical education, insight generation, congress strategy, advisory boards, and stakeholder engagement.
  • Partner with Commercial, Market Access, Regulatory, Patient Advocacy, Global Medical Affairs, and Clinical Development teams to ensure coordinated launch execution.
  • Identify and mitigate launch risks while addressing emerging opportunities and competitive dynamics.
Scientific Communications, Evidence Generation & Insights
  • Lead U.S. scientific communication and medical education strategies, including congress activities, scientific exchange, educational programs, and content development.
  • Ensure alignment of U.S. communication plans with global publication and evidence dissemination strategies.
  • Review and approve U.S. medical materials and ensure communications address stakeholder educational needs.
  • Drive insight generation processes and translate stakeholder insights into actionable recommendations that inform development, launch, and lifecycle strategies.
  • Provide U.S. strategic input into evidence generation priorities, study concepts, real-world evidence initiatives, publication planning, and data dissemination activities.
  • Monitor scientific, clinical, regulatory, policy, and competitive developments to inform decision-making.
External Engagement & Market Access
  • Build and maintain relationships with KOLs, investigators, healthcare professionals, patient advocacy organizations, professional societies, payers, and other stakeholders.
  • Lead advisory boards and expert consultation initiatives to inform medical strategy and evidence priorities.
  • Represent ITF Therapeutics at scientific, advocacy, and industry forums.
  • Partner with Market Access and HEOR to support generation and communication of evidence demonstrating clinical, economic, and patient-centered value.
  • Support payer-facing medical engagements and patient access objectives.
Cross-Functional & Global Collaboration
  • Serve as a strategic partner to Commercial, Clinical Development, Regulatory Affairs, Market Access, Safety, Patient Advocacy, and Global Medical Affairs teams.
  • Provide scientific leadership across key business decisions and strategic initiatives.
  • Act as the primary U.S. partner to the Global Neurometabolic Medical Director, contributing U.S. market insights to disease strategy, product strategy, lifecycle planning, evidence generation, publication priorities, and scientific platform development.
  • Ensure alignment between U.S. and global stakeholders, incorporating U.S. insights into global plans while maintaining the highest standards of scientific integrity and patient focus.
Team Leadership & Organizational Development
  • Build, lead, and develop a high-performing U.S. Medical Affairs neurometabolic team.
  • Coach and mentor team members, fostering accountability, collaboration, innovation, and scientific excellence.
  • Establish priorities, performance expectations, and development plans to support organizational growth and succession planning.
  • Promote a patient-centered culture that balances scientific rigor with meaningful healthcare impact.
Required Skills:
  • MD, PharmD, or PhD in a relevant scientific, medical, or healthcare discipline.
  • 12+ years of progressive pharmaceutical or biotechnology experience within Medical Affairs, Clinical Development, or related functions.
  • Demonstrated success leading U.S. Medical Affairs organizations and launch readiness activities for rare disease and/or specialty products. Experience in neurometabolic disease or lysosomal storage diseases preferred.
  • Experience partnering effectively with Global Medical Affairs teams in a matrixed multinational organization.
  • Proven ability to influence global strategy through U.S. market insights, external stakeholder engagement, and evidence generation planning.
  • Strong understanding of evidence generation, publication planning, scientific communications, medical governance, and healthcare decision-making processes.
  • Significant experience engaging KOLs, researchers, advocacy organizations, payers, and healthcare systems.
  • Demonstrated ability to operate strategically while driving flawless execution.
Preferred Skills:
  • Experience supporting product launches and pre-launch Medical Affairs activities.
  • Expertise in neurometabolic disorders, rare diseases, neuroscience, genetics, or related therapeutic areas.
  • Experience with insight generation, customer engagement platforms, and CRM systems.
  • Demonstrated success managing departmental budgets and resource planning.
  • Experience working in a global or matrixed organizational environment.
Additional Information:

The base compensation range for this role is: $290,000 - $320,000. Compensation is determined through an analytical approach utilizing a combination of factors including, but not limited to, relevant skills & experience, job location, and internal equity.

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Sr. Director, Medical Affairs, Neurometabolic Team
Sr. Director, Medical Affairs, Neurometabolic Team

ITF Therapeutics • Concord (MA)

On-site
USD 290,000 - 320,000
Senior Director, Medical Affairs — Rare Neurometabolic Diseases
Senior Director, Medical Affairs — Rare Neurometabolic Diseases

ITF Therapeutics • Concord (MA)

On-site
USD 290,000 - 320,000
Base salary with comprehensive package
Field Medical Director, Inherited Metabolic Disorders (IMD)
Field Medical Director, Inherited Metabolic Disorders (IMD)

ITF Therapeutics LLC • Kansas City (KS)

Remote
USD 250,000 - 270,000
Vice President, US Regulatory Affairs Concord, MA
Vice President, US Regulatory Affairs Concord, MA

ITF Therapeutics LLC • Concord (MA)

On-site
USD 330,000 - 370,000
Neurometabolic Medical Affairs Lead: Launch & Strategy
Neurometabolic Medical Affairs Lead: Launch & Strategy

ITF Therapeutics • Concord (MA)

On-site
USD 290,000 - 320,000
Vice President, US Regulatory Affairs
Vice President, US Regulatory Affairs

ITF Therapeutics LLC • Concord (MA)

On-site
USD 330,000 - 370,000
Executive Director, Head of US Rare Endocrinology and Rare Tumors
Executive Director, Head of US Rare Endocrinology and Rare Tumors

Alexion Pharmaceuticals, Inc. • Boston (MA)

Hybrid
USD 282,000 - 423,000
Hybrid work model
Chief of Staff
Chief of Staff

ITF Therapeutics LLC • Concord (MA)

On-site
USD 270,000 - 295,000
Head Rare Diseases, US Medical Affairs
Head Rare Diseases, US Medical Affairs

Biogen • Cambridge (MA)

On-site
USD 303,000 - 428,000
Key Account Manager
Key Account Manager

ITF Therapeutics • Chicago (IL)

On-site
USD 185,000 - 210,000